164 related articles for article (PubMed ID: 20701468)
1. Does C-reactive protein predict recurrent preeclampsia?
Gammill HS; Powers RW; Clifton RG; Van Dorsten JP; Klebanoff MA; Lindheimer MD; Sibai B; Landon MB; Miodovnik M; Dombrowski M;
Hypertens Pregnancy; 2010; 29(4):399-409. PubMed ID: 20701468
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein and fibrinogen levels as determinants of recurrent preeclampsia: a prospective cohort study.
van Rijn BB; Veerbeek JH; Scholtens LC; Post Uiterweer ED; Koster MP; Peeters LL; Koenen SV; Bruinse HW; Franx A
J Hypertens; 2014 Feb; 32(2):408-14. PubMed ID: 24351805
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of inflammatory markers neopterin, sialic acid, and C-reactive protein in pregnancy and preeclampsia.
von Versen-Hoeynck FM; Hubel CA; Gallaher MJ; Gammill HS; Powers RW
Am J Hypertens; 2009 Jun; 22(6):687-92. PubMed ID: 19282816
[TBL] [Abstract][Full Text] [Related]
4. Maternal periodontal disease, systemic inflammation, and risk for preeclampsia.
Ruma M; Boggess K; Moss K; Jared H; Murtha A; Beck J; Offenbacher S
Am J Obstet Gynecol; 2008 Apr; 198(4):389.e1-5. PubMed ID: 18295179
[TBL] [Abstract][Full Text] [Related]
5. A prospective study of maternal serum C-reactive protein concentrations and risk of preeclampsia.
Qiu C; Luthy DA; Zhang C; Walsh SW; Leisenring WM; Williams MA
Am J Hypertens; 2004 Feb; 17(2):154-60. PubMed ID: 14751658
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein, marker for evaluation of systemic inflammatory response in preeclampsia.
Mihu D; Costin N; Mihu CM; Blaga LD; Pop RB
Rev Med Chir Soc Med Nat Iasi; 2008; 112(4):1019-25. PubMed ID: 20209780
[TBL] [Abstract][Full Text] [Related]
7. Calprotectin, a marker of inflammation, is elevated in the maternal but not in the fetal circulation in preeclampsia.
Braekke K; Holthe MR; Harsem NK; Fagerhol MK; Staff AC
Am J Obstet Gynecol; 2005 Jul; 193(1):227-33. PubMed ID: 16021084
[TBL] [Abstract][Full Text] [Related]
8. Prediction of preeclampsia throughout gestation with maternal characteristics and biophysical and biochemical markers: a longitudinal study.
Tarca AL; Taran A; Romero R; Jung E; Paredes C; Bhatti G; Ghita C; Chaiworapongsa T; Than NG; Hsu CD
Am J Obstet Gynecol; 2022 Jan; 226(1):126.e1-126.e22. PubMed ID: 34998477
[TBL] [Abstract][Full Text] [Related]
9. Genetic predisposition to elevated levels of C-reactive protein is associated with a decreased risk for preeclampsia.
Spracklen CN; Smith CJ; Saftlas AF; Triche EW; Bjonnes A; Keating BJ; Saxena R; Breheny PJ; Dewan AT; Robinson JG; Hoh J; Ryckman KK
Hypertens Pregnancy; 2017 Feb; 36(1):30-35. PubMed ID: 27657194
[TBL] [Abstract][Full Text] [Related]
10. Ultra-high sensitive C-reactive protein during normal pregnancy and in preeclampsia: a pilot study.
Raio L; Bersinger NA; Malek A; Schneider H; Messerli FH; Hürter H; Rimoldi SF; Baumann MU
J Hypertens; 2019 May; 37(5):1012-1017. PubMed ID: 30882594
[TBL] [Abstract][Full Text] [Related]
11. The predictive value of the first-trimester maternal serum chemerin level for pre-eclampsia.
Xu QL; Zhu M; Jin Y; Wang N; Xu HX; Quan LM; Wang SS; Li SS
Peptides; 2014 Dec; 62():150-4. PubMed ID: 25445606
[TBL] [Abstract][Full Text] [Related]
12. Endogenous soluble receptor for advanced glycation endproducts is increased in preeclampsia.
Fasshauer M; Seeger J; Waldeyer T; Schrey S; Ebert T; Lossner U; Bluher M; Stumvoll M; Faber R; Stepan H
J Hypertens; 2008 Sep; 26(9):1824-8. PubMed ID: 18698218
[TBL] [Abstract][Full Text] [Related]
13. Repeated measures of inflammation and oxidative stress biomarkers in preeclamptic and normotensive pregnancies.
Ferguson KK; Meeker JD; McElrath TF; Mukherjee B; Cantonwine DE
Am J Obstet Gynecol; 2017 May; 216(5):527.e1-527.e9. PubMed ID: 28043842
[TBL] [Abstract][Full Text] [Related]
14. Preeclampsia in high risk women is characterized by risk group-specific abnormalities in serum biomarkers.
Metz TD; Allshouse AA; Euser AG; Heyborne KD
Am J Obstet Gynecol; 2014 Nov; 211(5):512.e1-6. PubMed ID: 24769011
[TBL] [Abstract][Full Text] [Related]
15. Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction.
Tjoa ML; van Vugt JM; Go AT; Blankenstein MA; Oudejans CB; van Wijk IJ
J Reprod Immunol; 2003 Jun; 59(1):29-37. PubMed ID: 12892901
[TBL] [Abstract][Full Text] [Related]
16. Early-pregnancy multiple serum markers and second-trimester uterine artery Doppler in predicting preeclampsia.
Thilaganathan B; Wormald B; Zanardini C; Sheldon J; Ralph E; Papageorghiou AT
Obstet Gynecol; 2010 Jun; 115(6):1233-1238. PubMed ID: 20502295
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of maternal systemic inflammatory response in preeclampsia.
Mihu D; Razvan C; Malutan A; Mihaela C
Taiwan J Obstet Gynecol; 2015 Apr; 54(2):160-6. PubMed ID: 25951721
[TBL] [Abstract][Full Text] [Related]
18. Postpartum Circulating Markers of Inflammation and the Systemic Acute-Phase Response After Early-Onset Preeclampsia.
van Rijn BB; Bruinse HW; Veerbeek JH; Post Uiterweer ED; Koenen SV; van der Bom JG; Rijkers GT; Roest M; Franx A
Hypertension; 2016 Feb; 67(2):404-14. PubMed ID: 26711734
[TBL] [Abstract][Full Text] [Related]
19. Relationship of Postpartum Levels of Cystatin and High-Sensitivity C-Reactive Protein and Duration of Lactation in Mothers with Previous Gestational Hypertension or Preeclampsia.
Countouris ME; Demirci JR; Jeyabalan A; Catov JM; Schwarz EB
Breastfeed Med; 2019; 14(6):408-415. PubMed ID: 30874448
[No Abstract] [Full Text] [Related]
20. Maternal plasma soluble TRAIL is decreased in preeclampsia.
Chaemsaithong P; Chaiworapongsa T; Romero R; Korzeniewski SJ; Stampalija T; Than NG; Dong Z; Miranda J; Yeo L; Hassan SS
J Matern Fetal Neonatal Med; 2014 Feb; 27(3):217-27. PubMed ID: 23688319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
